Abstract
Background
Kisspeptin has recently emerged as a key regulator of the reproductive axis in women. Kisspeptin, acting centrally via the kisspeptin receptor, stimulates the secretion of the gonadotrophin-releasing hormone (GnRH).
Aims
To investigate serum kisspeptin levels in infertility patients for its clinical utilisation in management and understanding of the pathophysiology of infertility in a wide array of patients.
Methods
This prospective case–control study analysis involved 92 primary infertile women with PCOS, diminished ovarian reserve (DOR), unexplained infertility (UEI), and male factor infertility between 20 and 42 years of age. Serum samples were collected between the second and fifth day of the menstrual cycle. The kisspeptin level was determined using a human kisspeptin ELISA kit according to the manufacturer’s procedure.
Results
The median value of serum kisspeptin in the PCOS infertility group was significantly higher than that in the UEI group (p = 0.011). There was a statistically significant (p = 0.015, r = −0.182) negative weak correlation found between serum kisspeptin levels and age. The optimal cutoff value obtained to differentiate the UEI from others (PCOS infertility + DOR + male factor infertility) according to the serum kisspeptin level was 214.3 ng/L with a sensitivity of 55% and specificity of 80.9%.
Conclusions
Understanding the role of kisspeptin may lead to its use as a biomarker in infertility diagnosis in UEI patients and might guide the use of kisspeptin analogues in selected patients for infertility management.
Similar content being viewed by others
Availability of data and materials
Statistical analysis of the data set during the current study is available at https://data.mendeley.com/drafts/tkt49875rc.
Abbreviations
- GnRH:
-
Gonadotropin-releasing hormone
- LH:
-
Luteinizing hormone
- E2:
-
Estradiol
- UEI:
-
Unexplained infertility
- ART:
-
Assisted reproductive technology
- HPO:
-
Hypothalamic pituitary ovarian axis
- BMI:
-
Body mass index
- DOR:
-
Diminished ovarian reserve
- PCOS:
-
Polycystic ovary syndrome
- AMH:
-
Anti-Mullerian hormone
References
Ruohonen ST, Poutanen M, Tena-Sempere M (2020) Role of kisspeptins in the control of the hypothalamic-pituitary-ovarian axis: old dogmas and new challenges. Fertil Steril 114(3):465–474
Siahpoosh Z, Farsimadan M, Pazhohan M et al (2021) KISS1R polymorphism rs587777844 (Tyr313His) is linked to female infertility. Br J Biomed Sci 78(2):98–100
Lee WL, Lee FK, Wang PH (2021) Kisspeptin in female reproduction. J Chin Med Assoc 84(6):559–560
Szydełko-Gorzkowicz M, Poniedziałek-Czajkowska E et al (2022) The role of kisspeptin in the pathogenesis of pregnancy complications: a narrative review. Int J Mol Sci 23(12):6611
Zhou P, Wu JA (2022) Novel KISS1R loss-of-function variant in a Chinese child with congenital hypogonadotropic hypogonadism. J Clin Res Pediatr Endocrinol. https://doi.org/10.4274/jcrpe.galenos.2022.2022-3-18
Hu KL, Chen Z, Li X et al (2022) Advances in clinical applications of kisspeptin-GnRH pathway in female reproduction. Reprod Biol Endocrinol 20:81
Amodei R, Jonker SS, Whitler W et al (2022) The GnRH antagonist degarelix suppresses gonadotropin secretion and pituitary sensitivity in midgestation sheep fetuses. Endocrinol 163(2):bqab262
Patterson M, Murphy KG, Thompson EL et al (2006) Administration of kisspeptin-54 into discrete regions of the hypothalamus potently increases plasma luteinising hormone and testosterone in male adult rats. J Neuroendocrinol 18(5):349–354
Zegers-Hochschild F, Adamson GD, Dyer S et al (2017) The international glossary on infertility and fertility care. Fertil Steril 108(3):393–406
Esteves SC, Schattman GL, Agarwal A (2015) Definitions and relevance of unexplained infertility in reproductive medicine. In: Schattman G, Esteves SC, Agarwal A (eds) Unexplained infertility: pathophysiology, evaluation and treatment, 1st edn. Springer, New York, pp 3–5
Jaiswal A, Baliu-Souza T, Turner K et al (2022) Sperm centriole assessment identifies male factor infertility in couples with unexplained infertility - a pilot study. Eur J Cell Biol 101(3):151243
ESHRE, ASRM (2004) Rotterdam Sponsored PCOS Consensus Workshop Group Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81:19–25
Cooper TG, Noonan E, von Eckardstein S et al (2010) World Health Organization reference values for human semen characteristics. Hum Reprod Update 16(3):231–245
World Health Organisation (2010) WHO laboratory manual for the examination and processing of human semen, 5th edn. World Health Organization, Geneva
Romanski PA, Bortoletto P, Rosenwaks Z et al (2020) Delay in IVF treatment up to 180 days does not affect pregnancy outcomes in women with diminished ovarian reserve. Hum Reprod 35:1630–1636
Gelbaya TA, Potdar N, Jeve YB et al (2014) Definition and epidemiology of unexplained infertility. Obstet Gynecol Surv 69(2):109–115
Ozkan ZS, Deveci D, Kumbak B et al (2014) What is the impact of Th1/Th2 ratio, SOCS3, IL17, and IL35 levels in unexplained infertility? J Reprod Immunol 103:53–58
Enciso M, Aizpurua J, Rodríguez-Estrada B et al (2021) The precise determination of the window of implantation significantly improves ART outcomes. Sci Rep 11(1):13420
Kaya C, Alay I, Babayeva G et al (2019) Serum kisspeptin levels in unexplained infertility, polycystic ovary syndrome, and male factor infertility. Gynecol Endocrinol 35:228–232
Mumtaz A, Khalid A, Jamil Z et al (2017) Kisspeptin: a potential factor for unexplained infertility and impaired embryo implantation. Int J Fertil Steril 11(2):99–104
Dungan HM, Gottsch ML, Zeng H et al (2007) The role of kisspeptin-GPR54 signaling in the tonic regulation and surge release of gonadotropin-releasing hormone/luteinizing hormone. J Neurosci 27(44):12088–12095
Narayanaswamy S, Jayasena CN, Ng N et al (2016) Subcutaneous infusion of kisspeptin-54 stimulates gonadotrophin release in women and the response correlates with basal oestradiol levels. Clin Endocrinol (Oxf) 84(6):939–945
Abbara A, Eng PC, Phylactou M et al (2020) Kisspeptin receptor agonist has therapeutic potential for female reproductive disorders. J Clin Invest 30(12):6739–6753
Rehman R, Zafar A, Ali AA et al (2020) Impact of serum and follicular fluid kisspeptin and estradiol on oocyte maturity and endometrial thickness among unexplained infertile females during ICSI. PLoS ONE 15(10):e0239142
Jamil Z, Fatima SS, Arif S et al (2017) Kisspeptin and embryo implantation after ICSI. Reprod Biomed Online 34(2):147–153
García-Ortega J, Pinto FM, Fernández-Sánchez M et al (2014) Expression of neurokinin B/NK3 receptor and kisspeptin/KISS1 receptor in human granulosa cells. Hum Reprod 29:2736–2746
Gaytan F, Garcia-Galiano D, Dorfman MD et al (2014) Kisspeptin receptor haplo-insufficiency causes premature ovarian failure despite preserved gonadotropin secretion. Endocrinology 155:3088–3997
Nandankar N, Negron AL, Wolfe AM et al (2021) Mice with targeted deletion of ARC kisspeptin exhibit immature gametogenesis and impaired fertility. Journal of the Endocrine Society 5:543–544
Blasco V, Pinto FM, Fernández-Atucha A et al (2020) Female infertility is associated with an altered expression of the neurokinin B/neurokinin B receptor and kisspeptin/kisspeptin receptor systems in ovarian granulosa and cumulus cells. Fertil Steril 114(4):869–878
Bódis J, Sulyok E, Kőszegi T et al (2020) Serum and follicular fluid levels of serotonin, kisspeptin, and brain-derived neurotrophic factor in patients undergoing in vitro fertilization: an observational study: neurohormones in patients receiving IVF. J Int Med Res 48(4):300060519879330
Ibrahim RO, Omer SH, Fattah CN (2020) The correlation between hormonal disturbance in PCOS women and serum level of kisspeptin. Int J Endocrinol 6237141. https://doi.org/10.1155/2020/6237141
Blasco V, Pinto FM, Fernández-Atucha A et al (2019) Altered expression of the kisspeptin/KISS1R and neurokinin B/NK3R systems in mural granulosa and cumulus cells of patients with polycystic ovarian syndrome. J Assist Reprod Genet 36(1):113–120
Navarro VM (2020) Metabolic regulation of kisspeptin - the link between energy balance and reproduction. Nat Rev Endocrinol 8:407–420
Backholer K, Smith JT, Rao A et al (2010) Kisspeptin cells in the ewe brain respond to leptin and communicate with neuropeptide y and proopiomelanocortin cells. Endocrinology 151:2233–2243
Emekci Ozay O, Ozay AC, Acar B et al (2016) Role of kisspeptin in polycystic ovary syndrome (PCOS). Gynecol Endocrinol 32(9):718–722
Acknowledgements
We gratefully acknowledge the guidance and assistance provided by Dr. Sener Yalcınkaya from the Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology and Infertility Clinic.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Atakul, N., Kılıc, B.S., Selek, S. et al. Kisspeptin: a potential therapeutic target in patients with unexplained infertility?. Ir J Med Sci 192, 1779–1784 (2023). https://doi.org/10.1007/s11845-022-03152-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11845-022-03152-1